Stock Track | 10x Genomics Soars 9.94% in Pre-Market on Multiple Analyst Target Price Raises

Stock Track
Feb 13

10x Genomics Inc (TXG) saw its stock price surge 9.94% during pre-market trading, indicating strong investor interest ahead of the regular session.

The significant price movement follows a series of positive analyst actions, with multiple financial institutions raising their target prices for the genomics company. Deutsche Bank increased its target to $17 from $16, JP Morgan raised to $17 from $15, Jefferies lifted to $21 from $17, Stifel boosted to $20 from $15, and TD Cowen moved to $19 from $18.

These coordinated analyst upgrades suggest growing optimism about 10x Genomics' business prospects and future performance, driving increased buying activity in the pre-market session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10